CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria.
Front Immunol. 2021 Jun 14;12:638485. doi: 10.3389/fimmu.2021.638485. eCollection 2021.
Cytotoxic T lymphocytes (CTLs) represent key immune effectors of the host response against chronic viruses, due to their cytotoxic response to virus-infected cells. In response to this selection pressure, viruses may accumulate escape mutations that evade CTL-mediated control. To study the emergence of CTL escape mutations, we employed the murine chronic infection model of lymphocytic choriomeningitis virus (LCMV). We developed an amplicon-based next-generation sequencing pipeline to detect low frequency mutations in the viral genome and identified non-synonymous mutations in the immunodominant LCMV CTL epitope, GP33-41, in infected wildtype mice. Infected Rag2-deficient mice lacking CTLs did not contain such viral mutations. By using transgenic mice with T cell receptors specific to GP33-41, we characterized the emergence of viral mutations in this epitope under varying selection pressure. We investigated the two most abundant viral mutations by employing reverse genetically engineered viral mutants encoding the respective mutations. These experiments provided evidence that these mutations prevent activation and expansion of epitope-specific CD8 T cells. Our findings on the mutational dynamics of CTL escape mutations in a widely-studied viral infection model contributes to our understanding of how chronic viruses interact with their host and evade the immune response. This may guide the development of future treatments and vaccines against chronic infections.
细胞毒性 T 淋巴细胞(CTL)是宿主针对慢性病毒反应的关键免疫效应物,因为它们对病毒感染的细胞具有细胞毒性反应。由于这种选择压力,病毒可能会积累逃逸 CTL 介导控制的突变。为了研究 CTL 逃逸突变的出现,我们采用了淋巴细胞性脉络丛脑膜炎病毒(LCMV)的小鼠慢性感染模型。我们开发了基于扩增子的下一代测序技术,以检测病毒基因组中的低频突变,并在感染野生型小鼠的免疫显性 LCMV CTL 表位 GP33-41 中鉴定出非同义突变。缺乏 CTL 的 Rag2 缺陷型感染小鼠不包含此类病毒突变。通过使用特异性针对 GP33-41 的 T 细胞受体的转基因小鼠,我们在不同选择压力下研究了该表位中病毒突变的出现。我们通过使用编码各自突变的反向遗传工程病毒突变体来研究两种最丰富的病毒突变。这些实验提供的证据表明,这些突变阻止了表位特异性 CD8 T 细胞的激活和扩增。我们在广泛研究的病毒感染模型中对 CTL 逃逸突变的突变动态的研究结果有助于我们了解慢性病毒如何与宿主相互作用并逃避免疫反应。这可能指导针对慢性感染的未来治疗和疫苗的开发。